Victor G. Gonzalez-Garcia

Mexicali, BCN 21000, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Modulation of pancreatic β-cell function by adaptogens: Emerging evidence and integrative therapeutic potential.

Modulation of pancreatic β-cell function by adaptogens: Emerging evidence and integrative therapeutic potential.

Journal: Fitoterapia

Published: March 22, 2026

Nrf2 Is Associated with Metastasis-Related Processes in a Chemoresistant Breast Cancer Model: Insights from siRNA Modulation.

Nrf2 Is Associated with Metastasis-Related Processes in a Chemoresistant Breast Cancer Model: Insights from siRNA Modulation.

Journal: International journal of molecular sciences

Published: February 07, 2026

Regulation of the HCK-GS-HIF1α axis, a promising druggable target for aggressive TNBC.

Regulation of the HCK-GS-HIF1α axis, a promising druggable target for aggressive TNBC.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 05, 2026

Markers of oxidative stress and its relationship with microvascular complications in patients with type 2 diabetes mellitus

Markers of oxidative stress and its relationship with microvascular complications in patients with type 2 diabetes mellitus

Journal: Nutricion hospitalaria

Published: November 06, 2025

Vitamin D as an Epigenetic Regulator: A Hypothetical Mechanism for Cancer Prevention via Inhibition of Oncogenic lncRNA HOTAIR.

Vitamin D as an Epigenetic Regulator: A Hypothetical Mechanism for Cancer Prevention via Inhibition of Oncogenic lncRNA HOTAIR.

Journal: International journal of molecular sciences

Published: July 04, 2025

The transition from preclinical to clinical obesity: the importance of a borderline stage.

The transition from preclinical to clinical obesity: the importance of a borderline stage.

Journal: Clinical science (London, England : 1979)

Published: April 21, 2025

The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model.

The translation factor eIF4E is a key mediator of doxorubicin resistance: insights from a triple-negative breast cancer model.

Journal: Scientific reports

Published: February 28, 2025

Lapatinib-Resistant HER2+ Breast Cancer Cells Are Associated with Dysregulation of MAPK and p70S6K/PDCD4 Pathways and Calcium Management, Influence of Cryptotanshinone.

Lapatinib-Resistant HER2+ Breast Cancer Cells Are Associated with Dysregulation of MAPK and p70S6K/PDCD4 Pathways and Calcium Management, Influence of Cryptotanshinone.

Journal: International journal of molecular sciences

Published: February 23, 2025

Potential Ligands to Resistin Against Prostate Cancer, Evaluated by Molecular Docking and In Vitro Assays to Develop an Anticancer Drug.

Potential Ligands to Resistin Against Prostate Cancer, Evaluated by Molecular Docking and In Vitro Assays to Develop an Anticancer Drug.

Journal: Chemistry & biodiversity

Published: January 15, 2025

Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model.

Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model.

Journal: Pharmaceutics

Published: July 07, 2024

Tamoxifen metabolites treatment promotes ERα+ transition to triple negative phenotype in vitro, effects of LDL in chemoresistance.

Tamoxifen metabolites treatment promotes ERα+ transition to triple negative phenotype in vitro, effects of LDL in chemoresistance.

Journal: Bioscience reports

Published: April 15, 2024

Potential Otubain1 Inhibitor, an Approach for a Treatment against Breast Cancer.

Potential Otubain1 Inhibitor, an Approach for a Treatment against Breast Cancer.

Journal: International journal of molecular and cellular medicine

Published: January 01, 2024

Showing 1-12 of 30

Last Updated: 09/26/2026